Dr. Juan Pablo García-Huidobro, a researcher at CEDENNA, received significant recognition for a life dedicated to scientific research, the training of new generations, and the advancement of knowledge in Chile, following his nomination for the 2026 National Prize for Natural Sciences.
The nomination, submitted by the University of Santiago, Chile, recognizes his/her extraordinary career in the field of experimental pharmacology and his/her pioneering role in introducing molecular pharmacology to the country, fostering a new way of understanding the cellular and molecular mechanisms underlying drug action.
With an extensive academic and scientific career, Dr. García-Huidobro has contributed significantly to the advancement of Chilean pharmacology and the development of advanced human capital, guiding numerous generations of researchers and health professionals.
Their work has helped strengthen the transition from a pharmacology focused on describing drug effects to a science based on the study of the molecular and cellular processes involved in their functioning. This approach has opened up new possibilities for developing more precise therapeutic strategies and for understanding various diseases.
Throughout his career, the researcher from the CEDENNA Nanosafety Laboratory has consistently pursued knowledge, conducting innovative research that links cell biology, chemical communication, and the potential development of new molecules with applications in health.
- Log in to post comments
